Alexandre Chlenski to Treatment Outcome
This is a "connection" page, showing publications Alexandre Chlenski has written about Treatment Outcome.
Connection Strength
0.015
-
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth. Pediatr Blood Cancer. 2011 Jan; 56(1):164-7.
Score: 0.008
-
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res. 2007 Jun 01; 13(11):3191-7.
Score: 0.007